Summary:
A Phase 3, Multicenter, Randomized, Double-blind Trial of Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Post-traumatic Stress Disorder
Qualified Participants Must:
18 to 65
PTSD Symptoms at least 6 months
Traumatic event was not greater than 9 years ago or before age 16
No traumatic events in past 3 months
Not receiving disability payments due to PTSD
Not in compensation litigation
Qualified Participants May Receive:
Investigational medications and compensation for time and travel